VT News
Igor Zhovkva

Igor Zhovkva

Ask VT AI
View News Summary
  • Eli Lilly's diabetes drug Mounjaro demonstrates an 8% greater reduction in major adverse cardiovascular events compared to its older GLP-1 drug Trulicity in a large trial, strengthening Lilly's position in the competitive GLP-1 market.
  • Vulcan Materials, a leading construction aggregates producer, reported mixed Q2 2025 results, with revenue missing estimates but adjusted earnings exceeding expectations despite weather and inflation challenges.
  • Trump's surprise exemption of refined copper from tariffs causes market turmoil, but experts warn of potential future tariffs on the metal.
20 hours
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Latest News
Ask VT AI
View News Summary
  • Eli Lilly's diabetes drug Mounjaro demonstrates an 8% greater reduction in major adverse cardiovascular events compared to its older GLP-1 drug Trulicity in a large trial, strengthening Lilly's position in the competitive GLP-1 market.
  • Vulcan Materials, a leading construction aggregates producer, reported mixed Q2 2025 results, with revenue missing estimates but adjusted earnings exceeding expectations despite weather and inflation challenges.
  • Trump's surprise exemption of refined copper from tariffs causes market turmoil, but experts warn of potential future tariffs on the metal.
20 hours
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Most Reported By
News from Igor Zhovkva

Top Topics

Trending in U.S.

World

Sport